-
Hope and Acceptance of AI-Guided Psychotherapy: Patient Adoption of Conversational AI in Mental Health Care
Sep 9, 2025, 16:22 PM -
What Is the Value of Large Language Models for Improving Extraction and Interpretation of Efficiency Data From French Commission Dévaluation Économique et de Santé Publique (CEESP): Decisions on Breast Cancer Medications?
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan
Sep 9, 2025, 16:22 PM -
Clinical and Economic Perspectives on Influenza and COVID-19 Vaccine Combinations
Sep 9, 2025, 16:22 PM -
Characterizing and Quantifying Impacts of Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers
Sep 9, 2025, 16:22 PM -
Can Intravitreal Aflibercept 8 mg Result in Decreased Treatment Burden and Treatment Costs in European Patients With Age-Related Macular Degeneration? Early Evidence From Clinical Practice
Sep 9, 2025, 16:22 PM -
The Rapid Involvement of Patients and the Public in Evidence Synthesis (RIPPLES) Framework: Development and Guidance
Sep 9, 2025, 16:22 PM -
Adjusting to Nonoverlapping Variables in the Unanchored Matching-Adjusted Indirect Comparisons of Survival Outcomes: Application of Monte Carlo Simulations
Sep 9, 2025, 16:22 PM -
AI-Assisted Systematic Literature Screening According to NICE, UK, and CDA (Canada) Position Papers: An HTA Submission Use Case
Sep 9, 2025, 16:22 PM -
Cardiovascular Implications of Loneliness and Social Isolation: Evidence From a Systematic Review
Sep 9, 2025, 16:22 PM -
Assessing the Quality and Determinants of Referrals From General Practitioners (Primary Care Physicians for Adults) to Specialist Physicians in the Cyprus Healthcare System
Sep 9, 2025, 16:22 PM -
Financial and Mental Health Burden on Caregivers of Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States
Sep 9, 2025, 16:22 PM -
Analysis of a Cancer Profile of 10 European States
Sep 9, 2025, 16:22 PM -
Perceived Impact and Actionability of Barriers to Drug Repurposing: Insights From a Multistakeholder Policy Survey
Sep 9, 2025, 16:22 PM -
Comparative Assessment of Health-Related Quality of Life Among the Lebanese Population Pre- and Post-COVID-19 Pandemic
Sep 9, 2025, 16:22 PM -
Analysis of Factors Behind Differences Between Official Drug Pricing and Cost-Effectiveness Evaluation in Japan and Policy Implications
Sep 9, 2025, 16:22 PM -
Analysis of the Breast Cancer Diagnosis Program: A Window of Opportunity
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Modeling Challenges and Trends in the Neoadjuvant and Perioperative Settings: A Review of NICE Oncology Submissions
Sep 9, 2025, 16:22 PM -
AI-Assisted Expert Computable Operation Definition (CODef) Development for Real-World Research
Sep 9, 2025, 16:22 PM -
Evaluation of the Implementation Effect of Medical Service Price Reforms: A Case Study of Assisted Reproductive Services in China
Sep 9, 2025, 16:22 PM
